Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
Positive controls provide quality control measures for the verification and validation for point-of-care diagnostic tests including both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) assays.
The RealLine SARS-Influenza A+B Kit is intended for the differential detection of the SARS-CoV-2 RNA with targetgenes E and N and the Influenza A and B Virus RNA RUO – Research Use Only
The RealLine SARS-CoV-2 kit is intended for the detection and differentiation of RNA of N-Gene and E-Gene from SARS-CoV-2 and SARS-like Coronaviruses by Real-Time PCR
MéCour Microplate Thermal Towers for Heating/Cooling as part of lab automation systems
The probe-based Vericheck ddPCR Mycoplasma detection Kit brings confidence in testing for mycoplasma contamination. The specificity and reproducibility of this kit allows for a precise measurement of 112 mycoplasma species using droplet digital PCR.
Crystal digital PCR™ is a high-precision digital PCR solution with up to 3-color target multiplexing and a flexible range of fluorophore compatibility. Using cutting-edge microfluidic innovation, the technology is based on partitioning a sample into a large array of 20,000-30,000 droplets. This unique feature combined with the use of a single consumable, simple and user friendly workflow, and a fast-time-to-results (2h30) set…
The Geode first partitions the sample into 20,000-30,000 droplets using pressure control and then a PCR reaction occurs in each of the individual droplets.
The Prism3 scans the chambers containing the droplets using three different fluorescence channels and provides droplet crystal images with a measure of the detected target nucleic acids.
Custom PC tower, screen, and peripherals allowing monitoring of the Prism3 instrument.
The pump supplies pressure to the Geode to help partition the sample into droplets.
The Sapphire chip consists of 4 chambers where the samples are partitioned into homogenous droplet crystals using cutting edge microfluidic technique, and an inlet and an outlet port for loading and recovering the sample from each chamber, respectively.
The Opal chip consists of 16 chambers where the samples are partitioned into homogenous droplet crystals using a cutting-edge microfluidic technique.
Stilla Technologies' naica ® multiplex PCR MIX is specially formulated to ensure optimal Crystal Digital PCR™ compatibility. Our line of reagents maximizes sensitivity by enabling high sample input capacity while ensuring flexible reaction assembly.
Stilla Technologies' naica ® multiplex PCR MIX is specially formulated to ensure optimal Crystal Digital PCR™ compatibility. Our line of reagents maximizes sensitivity by enabling high sample input capacity while ensuring flexible reaction assembly.
